{"name":"GigaGen, Inc.","slug":"gigagen-inc","ticker":"","exchange":"","domain":"gigagen.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOR3ZCVnMwV0FnZXIyVC1TbXBEQXRJeVdGakhWYXJ4N0NPTk42cGJHSEhYRkZCNzVGV2ZvRGJsMEx6b3QyOGVIR2JrSDJ2NWJDVHBNenFfUEVROXh4dkFGYko4d2VVcjQydzNVZXdsa2tyaEh4TGMycy1aZGFwOThNS0tHZ2RfVEtrRndINFNaQlctdWx2c0NzbTVUdUhMVkFBclJuY1N6eEw?oc=5","date":"2025-02-10","type":"deal","source":"Fierce Biotech","summary":"Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger - Fierce Biotech","headline":"Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOVGpWamtrZ3g1YURjTkxoYmJEV0JZV2NWNmdEeFE1UDBiYk5adEVtVHYyM3BQN2tpdGFBSFJxSmRXazFHNUdSZ3B3ck9YbHhwUE5aODFNLW9TdkpLYWg5ZHZ6ZkR6S2swX3BpVFhaRFBqQ1dlOGpITkZhb2NlYmpYSDh6OW5NTUNYMExyQmVuMENSUDR0alo1a1ZZZ2w2eXEtVnE0NmNjenJMemtoOVpRbkE2NGpveW1JZlBGV2loS0VpN01XX1FSdExHSXhlWjNqY2JiQ240ODhuakx2NHNtbll2MXNteGE4dUtRRVI0VU1SNGQ1ejNnSkt5ZEdpcTJGUWYwcUFjaUx5R2c3M3N2NWpiVFBkeXRI?oc=5","date":"2024-11-19","type":"trial","source":"globenewswire.com","summary":"GigaGen Doses First Patient in Phase 1 Trial of Recombinant - globenewswire.com","headline":"GigaGen Doses First Patient in Phase 1 Trial of Recombinant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNQmZVWjUxTTUyUDB6UERLR3liNlQ0c1R6cnhKVG5JQlV2STN6THBUOHloc3RfT0JKM2JOU2tGNENrMzY2TlJhTmdDdWRUc1R1Q0hSbHpLOTZRR2hYWXJmQ1ZzWEVCOFVuWnk4Q3ZjYWd6dFJITW1oNmotX2tqbGIwNndBWUlITU9FZzVnTG5mdUZRdFhrdTdCdm9aTm9wdHFjelpCamU5aw?oc=5","date":"2024-10-04","type":"pipeline","source":"Contagion Live","summary":"GigaGen's New Contract with BARDA for Polyclonal Antibody Development - Contagion Live","headline":"GigaGen's New Contract with BARDA for Polyclonal Antibody Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOS2tzdmwwR1hpSTRac0h6aFNuekppc1dvMXNpWGdTWkFVZjRjbWlCQlJ1LVRDcjN5RW9MZzh5NVduZGlkTHVzSjlBTTBzSUF5RDZmVjhmY003UkZNWkZYb0FYRnV6VDhnZkJWODVhRnpIZXJhSlB2NGtVUkNZbEpkWDBFT3RXRGFXNkhkQ3NNNjJ6NmlhbzJwUDdXY2V4T1h0RmwwV0tDSk5fRldvT0sxTWszeFo5NGxVcUxiOEYzLWVOWmF3OWU4UEVMb2NyZTc3NnJlUkQwYjFrMG1UZ25fUXFPY0ZlX0l5M3VJNlRSbHkzZEJqNE9VSkNRdTFfcVZCZXBqbUNuM1liMmJjZ1F6enZBOXJxdWs1?oc=5","date":"2024-05-20","type":"trial","source":"globenewswire.com","summary":"GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 - globenewswire.com","headline":"GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQUWJ2aERvVjBQWEFkX01oLWlHNF9GZFNTOEJaQl9wcF90VWhiRThGWFBaT0t0dUVWMEhYU0Y2eHF6T2tKeGJseEhZYUlFZkhnbXRzbm5MYV9ieDR0ak9rRWRXRVJMdjY4cC11NkFhT2xmM2NMeVpjV0RDLVUtZ1FobFNRZnRvYTU2ZDZVSkwtOC1IZ2tROU9feXlTSExCRlp6QTJER1JkeTJrUVJ5Zi1hMFhEOC0xdXhzV2xwYi1GSnNEdndQMzMyZVBtRE5PcFZsTnBoMHhTUmt4TFBCNU40UjJmaEtxLW5ydmZiRHhoNGUxeVk0Y1dhMHRUM2hTWkdtaXo0dVV5NDBVVkg4RHhlaGl3?oc=5","date":"2023-12-12","type":"regulatory","source":"globenewswire.com","summary":"GigaGen Receives FDA Clearance of IND to Begin Phase 1 - globenewswire.com","headline":"GigaGen Receives FDA Clearance of IND to Begin Phase 1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPSnljR0tsQndKV1hIX04zVjMwY2xLYmlfNmw3bVZlY2pIWHdVOXl5ZkJjbndLM1Z6OGs0OUx5eWE0Z0F0UF9DQTZUZ0VWYm5TOXlHbEM2Tlc4UmNqcThGTjVYdVNXczhFWkNxQno5R2w0ZkU3TDVPaWp0dmlSb0lhQVAzcTczWnhwYlJ0c1RoRFdoQUJTQUNUd2lVV0wxM09NZHdrUG5nc3N5R3RsZEpQaHB3M1d5NEI0QzZxOFRva3ZIakotVC1nTERjdGpoazI1X0NENU94UjllbFRwSUZHTTlzQ0RuZEl5T0hZa09WTnRpb3F1U2lwLW9lUmljcW42ODFqTG5vcGdWX19zUXBOaEh6c1A3R0lhVkVyaTE1bC02OE9XbVpBd2RzekpzUQ?oc=5","date":"2023-11-06","type":"trial","source":"globenewswire.com","summary":"GigaGen Presents IND-Enabling Data and Phase 1 Trial - globenewswire.com","headline":"GigaGen Presents IND-Enabling Data and Phase 1 Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxQbFlKODYxVXBYbFJMdmRTZTdjUkJJS19QWG1QbGdBbWhPRG9zZ0RibWxndjViOGxQUWViVUdaMDVoZkQ1U3d1QnZkN0JrUE1UdUZoQmhRdGFrV1hIQVJydzFuS0UzSWN2TzNHUDNaeDNmYjJ0Rnd1bjctNXpyWkYtQzhDdnlMVWtMWXFGM3RCUmVTSl81YzVTYV9WSkVra0RMZHUxVXgtYTVfNGpGbV9zcTAtM19rTTVYNUtjdUpDZTkwUXRGLTV4LVBTUmx1OE0xNm9ySkNwcVZQWFNDdW5TNHhla1BNTDVRcnM4emg1aFlSOXRLSVJHSnR4NFY2NkwwamxQTGdkdlZQOU8yaGFHb3Q2R3cwRE1LWHAtd2VLV256S3RnUEtINktpTWJHQUQwSUdpa2E5aw?oc=5","date":"2023-10-19","type":"pipeline","source":"globenewswire.com","summary":"GigaGen Granted Expansion of Contract with US Department of - globenewswire.com","headline":"GigaGen Granted Expansion of Contract with US Department of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPam40YzBxcGQ3dUVtZ256dy00TFVKdjRNVFhPT0dnZUU3dGotZFM0SXlWRmhlUElOS2paWEZ4VVlsc3owQTdNaldFc3M4RThtTVVYSXNiZFhPeVQ2aUZZWk9xREtYMzZLUWpacF85a1I1QUdPNXJUYlFmSVV4Nms4ZlNPMDVBTlh4UFNNbllrTjUtWDdqVHdvQkVPZEhBNVZzQk1RazZLSE5jREhncHFwNWw0dnk5dTJOYkRvRWN6UzRKaWhMdnIyNnpOSVRLV0VtcEdqa1BKWUN0QUhjc2lnNlFfSWNKUTlPSkhYejkzSlNJQXI3ZklHVUtmSQ?oc=5","date":"2023-09-28","type":"deal","source":"globenewswire.com","summary":"GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564 - globenewswire.com","headline":"GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNX0h0UjkxQjBzdThOOFhoYmJjMmcteW5mbHFPVkJobEVZRk1IREZ6eHFXdXNCOVpqWGxQOTg2OHFSdFhhOEZ0VFBmeXZabzUxTmxPdmVEcWNxVlNreXAzbkhUUkk5bFRvbHEzRVpodVFNRVg1engyd2FaMmt1OWstNHI3ZjQ?oc=5","date":"2019-08-01","type":"pipeline","source":"Pharma Voice","summary":"Entrepreneurs - Pharma Voice","headline":"Entrepreneurs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQdEVFa09UbkprM1JneGJValo2NHJPY2FQX0UyUGx0enNTakxQQi1TcFg1R0daRk9HaE9ab2s0Y1ZFbnlTMHBWOVItMzJ0UEFSclJMMjdwd1E5aXhDSDhYay04c0ZrYklDRzg4enNscDhDeWI1OFdPaXg2VVhIb1pBNl9aV0tjQ3JEUWtSbTNUYVdzekVQaE12eWpHX080SkpZQnRkckg4NWxHX3FhZHlzNDFDdw?oc=5","date":"2018-01-23","type":"pipeline","source":"PR Newswire","summary":"GigaGen Announces New Office Space in South San Francisco - PR Newswire","headline":"GigaGen Announces New Office Space in South San Francisco","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}